"We are full of enthusiasm knowing that in our lifetime serious drugs with the possibility of modifying neurodegenerative disease onset and progression will emerge. Unlike 20 years ago, there is enough information now to be very deliberate in pushing for drug discovery. 

For scientists like us, that is exhilarating." - Virginia M.-Y. Lee, PhD, Director, CNDR

Giving to CNDR

CNDR is an international leader in research and drug discovery for Alzheimer's disease (AD), Frontotemporal degeneration (FTD), Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), and other neurodegenerative diseases.

Your support will help accelerate the efforts to develop disease-modifying therapies and to improve the quality of life for those suffering from these devastating disorders.

Donate Now